The Polyclinic

Future of Healthcare

Omega Healthcare | April 18, 2022

Omega Healthcare, a leading technology-enabled healthcare management solutions provider,announced its acquisition of ApexonHealth, an AI and automation-based revenue cycle management and payor solutions provider, and Vasta Global, a provider of real-world data abstraction and analytics for the oncology market. ApexonHealth leverages its digital solutions to deliver comprehensive technology-enabled services for both providers and payors from revenue cycle management and coding ...

Cision PR Newswire | August 06, 2020

The global outbreak of the respiratory coronavirus disease COVID-19 has put healthcare systems across the globe under tremendous pressure and highlights the urgent need to advance toward smart healthcare systems. COVID-19 has also presented the perfect application scenario for the deployment of 5G networks in hospitals, doctors' practices, and social care environments. In line with this, global tech market advisory firm, ABI Research forecasts that by 2026, 5G will generate US$399.8 million ...

Health Technology

Dialyze Direct | July 28, 2022

Dialyze Direct, the nation’s leading provider of home hemodialysis services in Skilled Nursing Facilities. announced it has partnered with CommuniCare Family of Companies, one of the nation’s largest post-acute care providers, to conduct onsite hemodialysis services at its facilities around the U.S. Founded in 1984 on the philosophy of “Serving with Pride,” CommuniCare’s standard of excellence, which focuses on patient care and quality of life, mirrors ...

Health Technology

Antengene Corporation Limited | September 19, 2022

Antengene Corporation Limited a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for hematology and oncology, announced that ATG-101, the company's in-house developed novel PD-L1/4-1BB bispecific antibody, has been granted an Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA) for the treatment of pancreatic cancer. This ODD will help Antenge...